[Development trend of PET radiopharmaceuticals as post-FDG tumor imaging agents].
Kawai
Keiichi
K
D000596:Amino Acids / Q000378:metabolism; D015195:Drug Design; D005462:Fluorine Radioisotopes; D019788:Fluorodeoxyglucose F18; D006801:Humans; D000860:Hypoxia; D007553:Isotope Labeling; D008563:Membrane Lipids / Q000378:metabolism; D009696:Nucleic Acids / Q000378:metabolism; D049268:Positron-Emission Tomography; D019275:Radiopharmaceuticals
D000596:Amino Acids; D005462:Fluorine Radioisotopes; D008563:Membrane Lipids; D009696:Nucleic Acids; D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18